Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer Meeting Abstract


Authors: Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; Rosen, N.; Hudis, C.; Chandarlapaty, S.
Abstract Title: Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
Meeting Title: 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 72
Issue: 24 Suppl.
Meeting Dates: 2012 Dec 4-8
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2012-12-15
Language: English
ACCESSION: WOS:000209704901244
DOI: 10.1158/0008-5472.sabcs12-p5-18-04
PROVIDER: wos
Notes: Meeting Abstract: P5-18-04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Andrew D Seidman
    318 Seidman
  3. Clifford Hudis
    905 Hudis
  4. Larry Norton
    758 Norton
  5. Neal Rosen
    425 Rosen
  6. Harpreet Pannu
    22 Pannu
  7. Tari King
    186 King
  8. Devika Gajria
    31 Gajria
  9. Shanu Modi
    265 Modi
  10. Rita Sakr
    61 Sakr
  11. Angemael   Syldor
    7 Syldor